Advice
Following an abbreviated submission
lercanidipine 20mg tablet (Zanidip) is accepted for use in NHS Scotland for the treatment of mild to moderate essential hypertension in patients for whom this is an appropriate antihypertensive agent.
This new strength allows a reduction in the number of tablets administered at the maximum dose, at reduced cost compared with the formulation available previously
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- lercanidipine 20mg tablet (Zanidip)
- SMC ID:
- 315/06
- Indication:
- Hypertension
- Pharmaceutical company
- Recordati Pharmaceuticals
- BNF chapter
- Cardiovascular system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 09 October 2006